MolNFT v1 · #105580 · protein
Anti CD70 llama glama Fab 27B3
4R90 · Anti CD70 llama glama Fab 27B3 light chain: “Anti CD70 llama glama Fab 27B3”. X-ray diffraction, 1 ligand (CA), 3 pockets (best druggability 0.68). MolNFT v1 #105580 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4R90
- Type
- protein
- Length
- 434 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Anti CD70 llama glama Fab 27B3 light chain; Anti CD70 llama glama Fab 27B3 heavy chain
- Ligands
- CA
- Pockets
- 3 · best druggability 0.68
Structure
x-ray diffraction · 2 distinct chains · 9% helix, 51% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| L | Anti CD70 llama glama Fab 27B3 light chain | protein | 210 | 8% helix, 51% strand | — |
| H | Anti CD70 llama glama Fab 27B3 heavy chain | protein | 224 | 9% helix, 51% strand | — |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 851 | 0.68 | 0.75 | 79 | GOL |
| 2 | 136 | 0.43 | 0.76 | 29 | empty |
| 3 | 90 | 0.40 | 0.77 | 17 | empty |
Interfaces
1 interface between chains.
- L–H · 1812 Ų buried · 13 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 4 disulfide (disulfide).
Compared structures
- 4R90 · Anti CD70 Llama glama Fab 27B3 · the same entry in another collection · chain L against L, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 4R90 · PDBe 4R90
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.